Clinical Trial Update: Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score [Phase 4]

View source ↗

Summary

Phase 4 mechanistic trial assessing pharmacokinetics and pharmacodynamics of metoprolol in patients with heart failure with reduced ejection fraction, stratifie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: University of Michigan | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: RECRUITING